Celldex Therapeutics and Zacks Medical operated within the biomedical sector and underperformed the broader market index on August 8, 2025.
1 report, 1 independent
Updated Aug 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Celldex Therapeutics and Zacks Medical operated within the biomedical sector and underperformed the broader market index on August 8, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Celldex Therapeutics
American biopharmaceutical company
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- ZacksCelldex Therapeutics (CLDX) Reports Q2 Loss, Misses Revenue Estimates Celldex Therapeutics (CLDX) came out with a quarterly loss of $0.85 per share versus the Zacks Consensus Estimate of a loss of $0